MedTrace Logo

Clinical Utility Study for Exo-PDAC

NCT05702385 · Status: WITHDRAWN · Phase: NA · Type: INTERVENTIONAL

Last updated 2023-12-07

No results posted yet for this study

Summary

This is a national-level research study of oncologists, interventional gastroenterologists, and primary care providers. The purpose of this study is to assess the clinical evaluation and management (drug, procedures, counseling and other) of a subset of common patient care indications.

Conditions

  • Pancreas Cancer

Interventions

OTHER

Educational Materials for a new diagnostic test

These materials detail what the test does, how it is used, the validity and specifications of the test, and how to read its test report.

Sponsors & Collaborators

  • Qure Healthcare, LLC

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-09-01
Primary Completion
2023-10-31
Completion
2023-10-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05702385 on ClinicalTrials.gov